FDAsafety guidance77% confidence
FDA AP — BUPROPION HYDROCHLORIDE (ORIG)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Lupin; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA216051. Sponsor: AUROBINDO PHARMA LTD. Submission status: AP. Submission type: ORIG. Review priority: STANDARD. Active ingredients: BUPROPION HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Diabetes · Oral Hypoglycemic
- Sub-indication
- General
Related signal: Lupin's Metformin Hydrochloride ANDA090692 Receives AP Status from FDA